AtG Therapeutics

0 followers


AtG is a spin-off company from the Bellvitge Biomedical Research Institute (IDIBELL) and the Catalan Institute of Oncology (ICO) in Barcelona that specialized in the discovery and development of new therapeutic techniques for cancer resistance to improve the lives of cancer patients.

Headquarters

Barcelona, Spain

Employees

1-10

Links

Org chart

Itziar Canamasas, PhD
Strategic Advisor And Chairwoman

Itziar Canamasas, PhD

Collapse
Bart Huisken
Co-founder and strategic advisor
Gabriela Jiménez Valerio, PhD.
Co-Founder & COO at AtG Therapeutics
Oriol Casanovas
Co-Founder and Chief Scientific Officer

Teams

This company has no teams yet